Browsing Tag
chronic hepatitis B
5 posts
Precision BioSciences gets FDA clearance for ELIMINATE-B trial of PBGENE-HBV
Precision BioSciences has secured a major regulatory breakthrough as the U.S. Food and Drug Administration (FDA) granted clearance…
GSK advances in Hepatitis B cure with FDA’s fast track for bepirovirsen
In a significant development for the treatment of chronic hepatitis B (CHB), GSK plc (LSE/NYSE: GSK) has announced…
Wave Life Sciences, GSK partner on oligonucleotide-based gene therapies
Wave Life Sciences and GSK have forged a partnership to discover and develop oligonucleotide therapeutics, focusing on new…
Aligos Therapeutics stops development of CHB drug candidate ALG-010133
Aligos Therapeutics has stopped further development of ALG-010133, its STOPS drug candidate, in chronic hepatitis B (CHB) owing…
Antios Therapeutics begins phase 1 trial for ATI-2173, a chronic hepatitis B candidate
US biopharma company Antios Therapeutics has initiated its first-in-human phase 1 clinical trial for ATI-2173, a liver-targeted, orally-administered,…